KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iron Mountain (IRM) Total Liabilities (2016 - 2025)

Iron Mountain (IRM) has disclosed Total Liabilities for 17 consecutive years, with $22.1 billion as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 16.21% to $22.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.1 billion through Dec 2025, up 16.21% year-over-year, with the annual reading at $22.1 billion for FY2025, 16.21% up from the prior year.
  • Total Liabilities hit $22.1 billion in Q4 2025 for Iron Mountain, up from $21.5 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $22.1 billion in Q4 2025 to a low of $13.0 billion in Q1 2021.
  • Historically, Total Liabilities has averaged $16.9 billion across 5 years, with a median of $16.4 billion in 2023.
  • Biggest five-year swings in Total Liabilities: decreased 1.32% in 2021 and later grew 16.21% in 2025.
  • Year by year, Total Liabilities stood at $13.6 billion in 2021, then grew by 14.06% to $15.5 billion in 2022, then increased by 11.34% to $17.3 billion in 2023, then grew by 10.19% to $19.0 billion in 2024, then grew by 16.21% to $22.1 billion in 2025.
  • Business Quant data shows Total Liabilities for IRM at $22.1 billion in Q4 2025, $21.5 billion in Q3 2025, and $20.7 billion in Q2 2025.